Page last updated: 2024-09-04

fusidic acid and flupenthixol

fusidic acid has been researched along with flupenthixol in 1 studies

Compound Research Comparison

Studies
(fusidic acid)
Trials
(fusidic acid)
Recent Studies (post-2010)
(fusidic acid)
Studies
(flupenthixol)
Trials
(flupenthixol)
Recent Studies (post-2010) (flupenthixol)
1,74211734438018

Protein Interaction Comparison

ProteinTaxonomyfusidic acid (IC50)flupenthixol (IC50)
Ubiquitin carboxyl-terminal hydrolase 1Homo sapiens (human)7
Potassium channel subfamily K member 2Homo sapiens (human)2
DRattus norvegicus (Norway rat)0.003
D(3) dopamine receptorRattus norvegicus (Norway rat)0.003
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.003
D(4) dopamine receptorRattus norvegicus (Norway rat)0.003
D(2) dopamine receptorRattus norvegicus (Norway rat)0.003
WD repeat-containing protein 48Homo sapiens (human)7
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.0022

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1

Other Studies

1 other study(ies) available for fusidic acid and flupenthixol

ArticleYear
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008